Offer - Urjas Oil for just ₹ 1
Jakavi is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Primary Myelofibrosis. Jakavi also has some secondary and off-label uses. These are listed below.
The correct dosage of Jakavi depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Jakavi also has some side effects, the most common being Bruising or discoloration, Weight gain. Besides the aforementioned side effects, there are other adverse effects of Jakavi as well, which are listed below. Such side effects of Jakavi normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Jakavi has a Unknown effect for pregnant women and Unknown effect on lactating mothers. It is important to know if Jakavi has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Jakavi related warnings section.
Jakavi can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Jakavi in conditions like Drug Allergy, Anemia. Other contraindications of Jakavi have been discussed in the sections ahead.
Drug reaction of Jakavi with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Jakavi is safe while driving, and is addiction.
Jakavi is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Jakavi is used -
Severe
Moderate
Mild
Common
Is the use of Jakavi safe for pregnant women?
No research has been done to ascertain the safety of Jakavi in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Jakavi safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Jakavi for breastfeeding women are not known.
What is the effect of Jakavi on the Kidneys?
Jakavi can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Jakavi on the Liver?
There may be an adverse effect on the liver after taking Jakavi. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Jakavi on the Heart?
Jakavi may have mild side effects on the heart. Most people will never see any effect on the heart.
Jakavi should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Jakavi unless your doctor advises you to do so -
Is this Jakavi habit forming or addictive?
Forming a habit of Jakavi has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Jakavi does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Jakavi only on doctor's advice.
Is it able to treat mental disorders?
No, Jakavi cannot treat any kind of mental disorder.
Interaction between Food and Jakavi
There isn't any research available on the side effects of taking Jakavi with food.
Interaction between Alcohol and Jakavi
Information about the interaction of Jakavi and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jakafi™ (ruxolitinib)
